ANAB AnaptysBio, Inc
AnaptysBio, Inc (ANAB) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 37% planned / 63% discretionary
Largest single sale: $701.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Schmid John P. 3 fills | Director | Sell | 20,645 | $56.11 | $1.2M | 39,671 −34.2% of holding | |
| Faga Daniel 10 fills | President, CEO | Sell | 17,679 | $61.61 | $1.1M | 513,134 −3.3% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell 10b5-1 | 10,000 | $54.00 | $540.0K | 12,835 −43.8% of holding | |
| Marquet Magda 2 fills | Director | Sell | 11,000 | $48.23 | $530.5K | 11,640 −48.6% of holding | |
| Faga Daniel | President, CEO | Sell | 14,281 | $44.71 | $638.5K | 479,344 −2.9% of holding | |
| Lizzul Paul F. | Chief Medical Officer | Sell | 3,650 | $44.71 | $163.2K | 42,088 −8% of holding | |
| MULROY DENNIS | CHIEF FINANCIAL OFFICER | Sell | 2,515 | $44.71 | $112.4K | 21,852 −10.3% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell | 2,210 | $44.71 | $98.8K | 12,835 −14.7% of holding | |
| LOUMEAU ERIC J 4 fills | CHIEF LEGAL OFFICER | Sell | 9,639 | $45.56 | $439.2K | 16,779 −36.5% of holding | |
| Faga Daniel | President, CEO | Sell | 9,202 | $45.11 | $415.1K | 466,787 −1.9% of holding | |
| Lizzul Paul F. | Chief Medical Officer | Sell | 2,235 | $45.11 | $100.8K | 37,213 −5.7% of holding | |
| MULROY DENNIS | CHIEF FINANCIAL OFFICER | Sell | 1,908 | $45.11 | $86.1K | 17,667 −9.7% of holding | |
| Faga Daniel | President, CEO | Sell | 15,309 | $43.26 | $662.3K | 458,139 −3.2% of holding | |
| Lizzul Paul F. | Chief Medical Officer | Sell | 4,219 | $43.26 | $182.5K | 33,303 −11.2% of holding | |
| MULROY DENNIS | CHIEF FINANCIAL OFFICER | Sell | 3,363 | $43.26 | $145.5K | 14,330 −19% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell | 2,983 | $43.26 | $129.0K | 13,251 −18.4% of holding | |
| Ware J. Anthony | Director | Sell | 3,900 | $49.58 | $193.3K | 9,630 −28.8% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell 10b5-1 | 10,000 | $51.00 | $510.0K | 8,947 −52.8% of holding | |
| MULROY DENNIS | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 10,000 | $50.00 | $500.0K | 9,401 −51.5% of holding | |
| Lizzul Paul F. | Chief Medical Officer | Sell 10b5-1 | 1,500 | $50.00 | $75.0K | 26,967 −5.3% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell 10b5-1 | 141 | $46.99 | $6.6K | 8,947 −1.6% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell 10b5-1 | 10,000 | $46.00 | $460.0K | 9,088 −52.4% of holding | |
| MULROY DENNIS 2 fills | CHIEF FINANCIAL OFFICER | Sell 10b5-1 | 15,725 | $44.85 | $705.3K | 15,761 −49.9% of holding | |
| LOUMEAU ERIC J 2 fills | CHIEF LEGAL OFFICER | Sell 10b5-1 | 12,500 | $44.86 | $560.8K | 13,283 −48.5% of holding | |
| LOUMEAU ERIC J | CHIEF LEGAL OFFICER | Sell 10b5-1 | 8,240 | $29.00 | $239.0K | 9,088 −47.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.